Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers first international generic GLP-1 offering, demonstrating the companys ability to meet the unique needs of...